YUCAIPA, Calif., Feb. 2, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets: IGNT), a leading manufacturer of respiratory medical devices, recently announced today that it has received a purchase order from Dr. Gary Call, Chief Medical Officer at Bingham Memorial Hospital in Blackfoot, Idaho. The Oxyview Nasal Cannula is gaining recognition in the $4 Billion respiratory market as Ingen targets their projected $200M annual market in selling the Oxyview in to hospital markets worldwide.
A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7050
Dr. Gary Call, Chief Medical Officer at Bingham Memorial Hospital stated, "...we bought enough Oxyviews to ensure every one of the nursing home residents has flow in their cannulas." This occurred when Dr. Call and his staff discovered that it was not until the respiratory therapist was helping a patient back into their wheel chair, and lifted the liquid oxygen dispenser, that anyone had suspected the oxygen tank was empty. The early morning routine which the nursing home team had used for years to fill the individual patient tanks, had never failed, or so they thought. At first the defenses of the staff blamed it upon a faulty tank, but then the liquid oxygen supplier checked it out and could not find a problem. These small individual liquid tanks have to be lifted by the strap off of the back of the wheel chairs and allowed to stabilize, in order to tell whether the tank is empty, or are still capable of providing oxygen flow. With the tank resting in the back of the patient's chair, the indicator is always on red, always showing "empty." The nursing home staff had grown accustomed to seeing the tank gauge on empty, and had not developed a process to discern otherwise. Dr. Call further stated, "When the events depicted above came to our attention, we realized there must be other people who care that when a patient is connected to a source of oxygen, there is something flowing in the tube. We found those folks at Ingen Technologies, who developed the Oxyview. This simple device fits in-line on the cannula, indicating at a glance that there is flow in the tube. No longer does our staff have to lean down and lift the tank out of its bracket, let it find a balance point, before determining whether or not oxygen is available to the patient. For less money than the patient's trip to the emergency room cost, we bought enough Oxyviews to ensure every one of the nursing home residents has flow in their cannulas. "
Dr. Gary Call has been working as a board-certified anesthesiologist at Bingham Memorial Hospital since 1986, and now serves as a member of the Idaho Pain Group.
"Our Oxyview products will improve oxygen therapy and reduce malpractice costs associated with hospitals and oxygen providers, such as Lincare and Apria, the two largest oxygen providers in the USA. This is no joke, and a very serious matter when it comes to the giants of oxygen providers. Once the oxygen market recognizes the attributes of Oxyview for their patients, everyone will benefit. The savings in the provider's pockets is far greater than the small increase in the price of our Smart Cannula compared to the price of a conventional cannula without any means of measuring oxygen flow rate. The stockholders and investors in Ingen will see a great financial future and strong-hold of our products in the world market place," stated Scott R. Sand, Chief Executive Officer and Chairman of the Board.
http://www.binghammemorial.org/find-a-physician/Pain-Management/gary-call-d-o.html
http://www.medox-oxyview.com/http://www.oxyviewnasalcannula.com/AboutUs.html
About Ingen:
Ingen is an established medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the US, and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing US and Foreign Patents and a successful registration with the Food & Drug Administration. The company has domestic and global distribution with manufacture representative organizations, and OEM partners. In 2009 the Oxyview Nasal Cannula was introduced as the world's first oxygen cannula with an in-line pneumatic oxygen flow meter. In 2010 the company introduced the Oxyview Pulse Oximeter. The Oxyview product line is available to the home care markets, commercial medical markets, aviation, automotive, and government sources. The company is licensed with the Department of Health and Human Services, and manufactures its products in the State of California. With approximately 32 million US patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide, Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.
The Ingen Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2472
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.
